skip to Main Content

News

Highlights

Jazz and a journey to biotech: Issi Rozen brings creative spirit to IPI Board

Becoming a jazz guitarist starts with a soul-catching chord. That initial spark of inspiration is followed by hours of practice to learn scales and complex...

Read more

At IPI Surfacing, panel calls for long-overdue collaboration to improve antibody reliability and accessibility

In a perfect world, antibody reagents would be reliable. Their protein sequences would be accessible. Application testing would have been conducted before sales. And protein...

Read more

IPI broadens scientific expertise with new talent

In 2022, IPI successfully broadened its expertise and streamlined its pipeline by bringing in new scientists with diverse specialities and interests. These scientists, who've joined...

Read more

From president and CEO Ken Fasman: IPI in the midst of an exciting growth year

I joined the Institute for Protein Innovation in November 2022, coming from a long term in executive leadership at The Jackson Laboratory. Trained in biomedical...

Read more
IPI partnership with Addgene

The Institute for Protein Innovation and Addgene partner to accelerate biomedical discovery with the development and distribution of protein-binding reagents

Partnership joins two nonprofits with aligned missions to provide researchers with access to well-validated antibodies and other reagents—and expertise about where and how to use them Boston, June 8, 2023…

Man in suit speaks from podium with Institute for Protein Innovation banner.

IPI starts new chapter with game-changing gift: A Q&A with Tim Springer

Big philanthropic gifts can be powerful vehicles of transformation for any young organization. With a history of scientific renown and entrepreneurial success, Institute for Protein Innovation (IPI) cofounder Tim Springer,…

Man in office lined with awards.

Harvard professor and entrepreneur Tim Springer donates $210 million to the Institute for Protein Innovation

The gift further positions the emerging nonprofit to transform biomedical research with novel protein tools and expertise BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI), a nonprofit…

Woman in glasses wearing lab coat holding pad of paper.

Sophia Ulmer brings creativity and computational prowess to protein engineering

Art and science can seem at odds. But fundamentally, both focus on exploration and the discovery of the unknown. In the Institute for Protein Innovation (IPI) laboratory, Sophia Ulmer mixes…

Glowing AI generated image of six-pronged cell surface receptor.

Chasing a ‘quantum leap’ in cell surface biology: A Q&A with Junichi Takagi

Cell surface receptors are, by and large, the main molecular target for therapeutics. Also known as transmembrane receptors, they’re the targets of more than 60% of drugs today. But scientists…

Feature photo announcing IPI Surfacing, a symposium on June 15, 2023 from 8 a.m. to 6:30 p.m. at the Joseph B. Martin Conference Center.

Institute for Protein Innovation welcomes top researchers at first symposium

BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI) will host IPI Surfacing, a symposium on cell surface receptor biology, on Thursday, June 15, 2023. The free, day-long…

Screenshot of video showing integrin mechanotransduction.

Uncovering the secrets of mechanotransduction, one integrin receptor at a time

For the body to function, cells must decide. Embryonic cells elect to reproduce and shape into budding limbs. Immune cells choose to leave the bloodstream en route to an infection…

Scientist viewing robot in lab.

Engineering Protein A to Z for VH3 antibody purification

Antibody purification is often taken for granted. It’s an essential step in isolating desirable antibodies for research and drug development and a standard part of antibody production at the Institute…

Hand holding pipette and tube.

Inside the IPI pipeline

Of the tools underpinning biomedical research, antibodies are among the most impactful. Their ability to recognize and attach to biomolecules has powered fundamental discoveries, diagnostic methods and treatments for diseases,…

Institute for Protein Innovation welcomes esteemed industry leader Kenneth Fasman,  Ph.D. as president and chief executive officer

Institute for Protein Innovation welcomes esteemed industry leader Kenneth Fasman, Ph.D. as president and chief executive officer

Boston, November 15, 2022 — The Institute for Protein Innovation (IPI), a nonprofit research organization advancing protein science to accelerate biomedical research and improve human health, today announced the appointment…

Crowd listens to six researchers discuss antibody access and reproducibility on a small stage.

At IPI Surfacing, panel calls for long-overdue collaboration to improve antibody reliability and accessibility

In a perfect world, antibody reagents would be reliable. Their protein sequences would be accessible. Application testing would have been conducted before sales. And protein tools would be affordable, proffered…

Screenshot of video showing integrin mechanotransduction.

Uncovering the secrets of mechanotransduction, one integrin receptor at a time

For the body to function, cells must decide. Embryonic cells elect to reproduce and shape into budding limbs. Immune cells choose to leave the bloodstream en route to an infection…

New federation aims to transform biology with protein tools spanning proteome by 2035

New federation aims to transform biology with protein tools spanning proteome by 2035

An ambitious protein moonshot is gaining momentum to develop and widely share tools that will land us understanding of the complete human proteome. In 2003, biology was all about the…

A man in a lab

From Rob Meijers, interim executive director: In 2021, IPI explored ‘new frontiers’ in antigen and antibody discovery

As the world struggled to live in and through a seeming “forever pandemic,” 2021 was a year that demanded global resilience. The potency of delta followed by fast spread of…

A person holding a vial

Antibodies are going from biology’s workhorses to precision tools, a boon for reliable research

Roughly a decade ago, biologists conducting high-stakes experiments noticed a pattern: Many findings couldn’t be replicated in other labs, throwing doubt on data that should have led to treatments for…

The German translation for opioid

The German translation for opioid

An opioid crisis in the US is not news. Indeed, the Centers for Disease Control and Prevention estimate nearly 841,000 people in the US have died in the last two…

Issi Rozen playing his guitar and leaning against a distressed brick wall.

Jazz and a journey to biotech: Issi Rozen brings creative spirit to IPI Board

Becoming a jazz guitarist starts with a soul-catching chord. That initial spark of inspiration is followed by hours of practice to learn scales and complex harmonies, decades of determination to…

Three photos picturing Deepash Kothiwal working in the lab, Mahesh Vangala smiling in front of a computer with antibody data, and Nirakar Basnet looking at protein images.

IPI broadens scientific expertise with new talent

In 2022, IPI successfully broadened its expertise and streamlined its pipeline by bringing in new scientists with diverse specialities and interests. These scientists, who’ve joined IPI from around the world,…

Two men talking in office building.

From president and CEO Ken Fasman: IPI in the midst of an exciting growth year

I joined the Institute for Protein Innovation in November 2022, coming from a long term in executive leadership at The Jackson Laboratory. Trained in biomedical engineering, neuroscience and genomics, and…

Man in suit speaks from podium with Institute for Protein Innovation banner.

IPI starts new chapter with game-changing gift: A Q&A with Tim Springer

Big philanthropic gifts can be powerful vehicles of transformation for any young organization. With a history of scientific renown and entrepreneurial success, Institute for Protein Innovation (IPI) cofounder Tim Springer,…

Woman in glasses wearing lab coat holding pad of paper.

Sophia Ulmer brings creativity and computational prowess to protein engineering

Art and science can seem at odds. But fundamentally, both focus on exploration and the discovery of the unknown. In the Institute for Protein Innovation (IPI) laboratory, Sophia Ulmer mixes…

Glowing AI generated image of six-pronged cell surface receptor.

Chasing a ‘quantum leap’ in cell surface biology: A Q&A with Junichi Takagi

Cell surface receptors are, by and large, the main molecular target for therapeutics. Also known as transmembrane receptors, they’re the targets of more than 60% of drugs today. But scientists…

Bioscience leader Ken Fasman to steer IPI as new president and CEO

Bioscience leader Ken Fasman to steer IPI as new president and CEO

The walls of Ken Fasman’s ninth-floor office are still bare. But the new president and CEO at the Institute for Protein Innovation (IPI) has plans that could fill the room.…

A group standing in front of a building

Dream come true: Zehra Sayers builds structural biology for the next generations

Zehra Sayers always dreamed of finding precise answers to life’s core questions. A professor and former president of Turkey’s Sabancı University — and one of the BBC’s most influential women…

Scientists standing in protein production laboratory

With a modern take on a family legacy, Stephen Blacklow joins IPI to push bioscience forward

Stephen Blacklow has biomedical curiosity in his genes. As the newest Board of Directors member at the Institute for Protein Innovation (IPI) and the Gustavus Adolphus Pfeiffer Professor and chair…

A man at a desk with awards linking the window behind.

IPI co-founder Timothy Springer wins Lasker Award, highlighting key chapter in biology

Scientist, entrepreneur and philanthropist Timothy Springer is one of three scientists to win the 2022 Albert Lasker Award for Basic Medical Research, widely regarded as America’s top biomedical research prize.…

Scientist viewing robot in lab.

Engineering Protein A to Z for VH3 antibody purification

Antibody purification is often taken for granted. It’s an essential step in isolating desirable antibodies for research and drug development and a standard part of antibody production at the Institute…

Hand holding pipette and tube.

Inside the IPI pipeline

Of the tools underpinning biomedical research, antibodies are among the most impactful. Their ability to recognize and attach to biomolecules has powered fundamental discoveries, diagnostic methods and treatments for diseases,…

Three dimensional structure of an integrin

Integrins: Explained

More than 600 million years ago, out of the depths of the metazoa, a protein family emerged — one that would persist through evolution and come to shape life today.…

IPI partnership with Addgene

The Institute for Protein Innovation and Addgene partner to accelerate biomedical discovery with the development and distribution of protein-binding reagents

Partnership joins two nonprofits with aligned missions to provide researchers with access to well-validated antibodies and other reagents—and expertise about where and how to use them Boston, June 8, 2023…

Man in office lined with awards.

Harvard professor and entrepreneur Tim Springer donates $210 million to the Institute for Protein Innovation

The gift further positions the emerging nonprofit to transform biomedical research with novel protein tools and expertise BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI), a nonprofit…

Feature photo announcing IPI Surfacing, a symposium on June 15, 2023 from 8 a.m. to 6:30 p.m. at the Joseph B. Martin Conference Center.

Institute for Protein Innovation welcomes top researchers at first symposium

BOSTON, March 29, 2023 — The Institute for Protein Innovation (IPI) will host IPI Surfacing, a symposium on cell surface receptor biology, on Thursday, June 15, 2023. The free, day-long…

Institute for Protein Innovation welcomes esteemed industry leader Kenneth Fasman,  Ph.D. as president and chief executive officer

Institute for Protein Innovation welcomes esteemed industry leader Kenneth Fasman, Ph.D. as president and chief executive officer

Boston, November 15, 2022 — The Institute for Protein Innovation (IPI), a nonprofit research organization advancing protein science to accelerate biomedical research and improve human health, today announced the appointment…

A man pointing to a computer screen

AI Proteins secures $18.2 million seed round to pioneer high-throughput platform for advanced miniprotein therapeutics

Company to focus on the rapid development of miniproteins tailor-made for therapeutics, driving down costs and shortening the time required to develop safer, more effective medicines. BOSTON—(BUSINESS WIRE)—AI Proteins, the…

A man at a desk with awards linking the window behind.

IPI co-founder Timothy Springer wins Lasker Award, highlighting key chapter in biology

Scientist, entrepreneur and philanthropist Timothy Springer is one of three scientists to win the 2022 Albert Lasker Award for Basic Medical Research, widely regarded as America’s top biomedical research prize.…

IPI joins an exciting effort to solve the reproducibility crisis

IPI joins an exciting effort to solve the reproducibility crisis

IPI is thrilled to join YCharOS as a member of its new Industry Advisory Committee. The Canadian company, named from a truncation of Antibody Characterization through Open Science, is launching…

Christopher Bahl selected as a TED Fellow

Christopher Bahl selected as a TED Fellow

Institute for Protein Innovation Head of Protein Design to present at TED2019, joining the newest class of 20 global visionaries. BOSTON, Jan. 23, 2019 /PRNewswire/ — Molecular Engineer Chris Bahl…

IPI appoints Wei Yang as director of target discovery and Sharon Klein as director of philanthropy

IPI appoints Wei Yang as director of target discovery and Sharon Klein as director of philanthropy

Boston, June 26, 2018 /PR Newswire/ – Institute for Protein Innovation (IPI), a non-profit research organization focused on empowering research in protein science and developing open-source monoclonal antibodies, announced today…

IPI relocates to Boston’s Longwood Medical and Academic Area

IPI relocates to Boston’s Longwood Medical and Academic Area

BOSTON, May 21, 2018 /PRNewswire/ — Just one year after launch, IPI has relocated to the Harvard Institutes of Medicine at 4 Blackfan Circle, Boston. The 12,000-square-foot lab space represents a dramatic expansion and…

Get in touch today

Back To Top